Manage Tickers Link Financial Account

Has my stock been accused of fraud?Join over 160k users who know.

Ticker	Price	Change($)	Change(%)	Shares	Volume	Prev Close	Open	Gain($)	Gain(%)

Ticker	Status	Jurisdiction	Filing Date	CP Start	CP End	CP Loss	Deadline

Ticker	Case Name	Status	CP Start	CP End	Deadline	Settlement Amt

Ticker	Name	Date	Analyst Firm	Up/Down	Target ($)	Rating Change	Rating Current

Sangamo Therapeutics Announces Pfizer's Phase 3 Trial Of Giroctocogene Fitelparvovec Meets Primary And Key Secondary Objectives; Eligible For Up To $220M In Milestone Payments And 14%-20% Royalties If Approved And Commercialized

Author: Benzinga Newsdesk | July 24, 2024 08:28am

Posted In: PFE SGMO